About ImmuCell
ImmuCell is a company based in Portland (United States) founded in 1982. It operates as a Direct-to-Consumer (D2C), and Reseller / Distribution. The company has 75 employees as of December 31, 2024. ImmuCell offers products and services including First Defense and Re-Tain.
- Headquarter Portland, United States
- Employees 75 as on 31 Dec, 2024
- Stage Public
-
Sectors
Agriculture
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Immucell Corporation
-
Annual Revenue
$26.49 M51.64as on Dec 31, 2024
-
Net Profit
$-2.16 M62.65as on Dec 31, 2024
-
EBITDA
$1.05 M0as on Dec 31, 2024
-
Latest Funding Round
$4.25 M (USD), Post-IPO
Apr 14, 2021
- Investors
-
Employee Count
75
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ImmuCell
ImmuCell is a publicly listed company on the NASDAQ with ticker symbol ICCC in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of ImmuCell
ImmuCell offers a comprehensive portfolio of products and services, including First Defense and Re-Tain. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Scours prevention for calves using colostrum-derived antibodies.
Intramammary treatment for subclinical mastitis in dairy.
Unlock access to complete
Funding Insights of ImmuCell
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $4.2M
-
First Round
First Round
(21 Oct 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Post-IPO - ImmuCell | Valuation |
investors |
|
| Jul, 2017 | Amount | Post-IPO - ImmuCell | Valuation |
investors |
|
| Mar, 2017 | Amount | Debt – Conventional - ImmuCell | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ImmuCell
ImmuCell has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include TD Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Financial services are offered through diverse subsidiaries.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ImmuCell
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ImmuCell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Immucell Comparisons
Competitors of ImmuCell
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Immucell
Frequently Asked Questions about ImmuCell
When was ImmuCell founded?
ImmuCell was founded in 1982 and raised its 1st funding round 34 years after it was founded.
Where is ImmuCell located?
ImmuCell is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
How many employees does ImmuCell have?
As of Dec 31, 2024, the latest employee count at ImmuCell is 75.
What is the annual revenue of ImmuCell?
Annual revenue of ImmuCell is $26.49M as on Dec 31, 2024.
What does ImmuCell do?
ImmuCell is engaged in developing, manufacturing, and marketing scientifically-proven products aimed at maximizing the genetic potential of dairy and beef cattle through disease prevention. Solutions are provided to address major issues like calf scours and mastitis, reducing reliance on antibiotics. The company operates within the animal health sector, offering innovative treatments and preventatives such as First Defense for scours and Re-Tain for mastitis. Commitment is shown to regulatory standards and customer-focused, cost-effective operations.
What products or services does ImmuCell offer?
ImmuCell offers First Defense and Re-Tain.
Is ImmuCell publicly traded?
Yes, ImmuCell is publicly traded on NASDAQ under the ticker symbol ICCC.
Who are ImmuCell's investors?
ImmuCell has 1 investor. Key investors include TD Bank.
What is ImmuCell's ticker symbol?
The ticker symbol of ImmuCell is ICCC on NASDAQ.